Phase I Trial of Cyclophosphamide as an Immune Modulator for Optimizing Oncolytic Reovirus Delivery to Solid Tumors

V Roulstone; K Khan; HS Pandha; S Rudman; M Coffey; GM Gill; AA Melcher; R Vile; KJ Harrington; J de Bono; J Spicer

doi:10.1158/1078-0432.CCR-14-1770

Back

Phase I Trial of Cyclophosphamide as an Immune Modulator for Optimizing Oncolytic Reovirus Delivery to Solid Tumors

Journal article

Peer reviewed

Phase I Trial of Cyclophosphamide as an Immune Modulator for Optimizing Oncolytic Reovirus Delivery to Solid Tumors

V Roulstone, K Khan, HS Pandha, S Rudman, M Coffey, GM Gill, AA Melcher, R Vile, KJ Harrington, J de Bono, …

CLINICAL CANCER RESEARCH, Vol.21(6), pp.1305-1312

15/03/2015

DOI: https://doi.org/10.1158/1078-0432.CCR-14-1770

Abstract

Science & Technology

Life Sciences & Biomedicine

Oncology

ADVANCED CANCER

TYPE-3

CHEMOTHERAPY

CYCLOSPORINE

COMBINATION

EFFICACY

THERAPY

INNATE

I/II

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000352071200011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View

Author

Metrics

31 Record Views

37 Times Cited - Web of Science

See more details

Details

Title: Phase I Trial of Cyclophosphamide as an Immune Modulator for Optimizing Oncolytic Reovirus Delivery to Solid Tumors
Creators: V Roulstone
K Khan
HS Pandha
S Rudman
M Coffey
GM Gill
AA Melcher
R Vile
KJ Harrington
J de Bono
J Spicer
Publication Details: CLINICAL CANCER RESEARCH, Vol.21(6), pp.1305-1312
Publisher: AMER ASSOC CANCER RESEARCH
Date published: 15/03/2015
Date submitted: 17/05/2017
Identifiers: 99513577602346
Academic Unit: University of Surrey
Language: English
Resource Type: Journal article

Phase I Trial of Cyclophosphamide as an Immune Modulator for Optimizing Oncolytic Reovirus Delivery to Solid Tumors

Abstract

Files and links (1)

Metrics

Details

Usage Policy